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Expression and characterization of a histidine-rich protein, Hpn: potential
for Ni2+ storage in Helicobacter pylori
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*Department of Chemistry and Open Laboratory of Chemical Biology, The University of Hong Kong, Pokfulam, Hong Kong, People’s Republic of China, and †Department of
Biochemistry, The University of Hong Kong, Pokfulam, Hong Kong, People’s Republic of China
Hpn is a small cytoplasmic protein found in Helicobacter
pylori, which binds Ni2+ ions with moderate affinity. Consisting
of 60 amino acids, the protein is rich in histidine (28 residues,
46.7%), as well as glutamate, glycine and serine residues (in total
31.7%), and contains short repeating motifs. In the present study,
we report the detailed biophysical characterization of the multi-
meric status and Ni2+-binding properties of purified recombinant
Hpn under physiologically relevant conditions. The protein exists
as an equilibration of multimeric forms in solution, with 20-mers
(approx. 136 kDa) being the predominant species. Using equili-
brium dialysis, ICP-MS (inductively coupled plasma MS) and
UV/visible spectroscopy, Hpnwas found to bind fiveNi2+ ions per
monomer at pH 7.4, with a dissociation constant (Kd) of 7.1 μM.
Importantly, Ni2+ binding to Hpn is reversible: metal is re-
leased either in the presence of a chelating ligand such as EDTA,
or at a slightly acidic pH (pH for half dissociation, pH1/2 ∼6.3).Ni2+ binding induces conformational changes within the protein,
increasing β-sheet and reducing α-helical content, from 22%
to 37%, and 20% to 10% respectively. Growth curves of
Escherichia coli BL21(DE3) both with and without the hpn gene
performed under Ni2+ pressure clearly implied a role for Hpn
to protect the cells from higher concentrations of external metal
ions. Similarly, the accumulation of Ni2+ in these cells expressing
Hpn from a plasmid was approx. 4-fold higher than in uninduced
controls or control cultures that lacked the plasmid. Similarly,
levels of Ni2+ in wild-type H. pylori 26695 cells were higher
than those in H. pylori hpn-deletion mutant strains. Hpn may
potentially serve multiple roles inside the bacterium: storage of
Ni2+ ions in a ‘reservoir’; donation of Ni2+ to other proteins; and
detoxification via sequestration of excess Ni2+.
Key words: Helicobacter pylori, histidine-rich protein, Hpn,
nickel, storage.
INTRODUCTION
Helicobacter pylori is a Gram-negative bacterium that colonizes
the gastric mucosa of humans [1], and has been shown to be the
causative agent of type B gastritis and peptic ulcerations [2–4].
The development of gastric carcinoma and MALT (mucosa-
associated lymphoid tissue) lymphoma are also strongly asso-
ciated with chronic H. pylori infection [5,6]. To colonize and
establish infection, H. pylori must produce an assortment of
factors to generate a neutral pH in order to survive the extremely
acidic environment in the stomach. One of them is a membrane-
bound [Ni–Fe] hydrogen-uptake hydrogenase, which permits
respiratory-based energy production for the bacteria in the
mucosa [7,8]. Another is urease, a dinuclear Ni2+-containing
metalloenzyme that accounts for up to 6% of the soluble cellular
proteins [9–11], which catalyses the hydrolysis of urea to yield
ammonia and carbamate to neutralize the gastric acid, critical for
H. pylori’s colonization and survival at acidic pH [12].
A constant supply of Ni2+ ions into H. pylori is therefore
required for the synthesis and activity of these Ni2+-containing
metalloenzymes. To date, members of two general types of Ni2+-
specific, membrane-integrated uptake systems have been identi-
fied in H. pylori [13]: (i) the multiple-component ABC (ATP-
binding cassette) transporters,which are believed to be a four-gene
operon designated as abcABCD [14]; and (ii) the nickel–cobalt
transporter family, comprising the putatively monomeric NixA
protein [15].
However, when excess Ni2+ ions accumulate, they inhibit
growth and exhibit toxic effects as a result of interference with
normal protein–metal binding and catalysis, as well as the gen-
eration of reactive oxygen species [16–18]. The toxicity of metal
ions is minimized through the strict control of their intracellular
concentrations, which is generally achieved through two pro-
cesses: regulation of ion transport, i.e. import and efflux from the
cell, and sequestration, through the formation of tight complexes
withmetal-storage proteins [19,20]. As in other bacteria,H. pylori
has to strike a delicate balance between the import of Ni2+ ions,
their efficient intracellular storage and delivery to Ni2+-dependent
metalloenzymes when required.
The completion of the H. pylori genome sequence has re-
vealed the presence of several putative ion-binding proteins and
membrane transporters that are involved in the transport and cyto-
plasmic accumulation of bivalent cations [21]. As mentioned
above, integral membrane proteins, such as the NixA and the
abcABCD transporters, scavenge Ni2+ ions from the surrounding
milieu and import them into the cell. In addition, two proteins with
a high affinity for Ni2+ ions have been characterized in H. pylori:
the HspA heat-shock protein, a bacterial GroES homologue with
a unique histidine-rich C-terminal domain [22], and an unusual
protein called Hpn, which is abundant in the cell cytoplasm,
accounting for approx. 2% of all protein synthesized [23]. As
described previously [23], Hpn consists of 60 amino acids,
including 28 histidine residues (Figure 1). The majority of the
histidine residues are located within the central part of the protein
(from residue 11 to residue 33) and include two separate stretches
of six and seven consecutive histidine residues. There are two in-
ternal short repeats of Glu-Glu-Gly-Cys-Cys, at positions 38–42
and 51–55, four sets of paired histidine residues (one near the
Abbreviations used: ABC, ATP-binding cassette; Amp, ampicillin; DTT, dithiothreitol; ICP-MS, inductively coupled plasma MS; IPTG, isopropyl β-D-
thiogalactoside; LB, Luria–Bertani; LMCT, ligand-to-metal charge transfer; MALDI, matrix-assisted laser-desorption ionization; MT, metallothionein; TTBS,
Tris-buffered saline with Tween 20; UV/vis, UV/visible.
1 Correspondence may be addressed to either of these authors (email jdhuang@hkucc.hku.hk or hsun@hkucc.hku.hk).
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Figure 1 Amino acid sequence of Hpn from H. pylori
Histidine residues are in bold, and the two EEGCC pentapeptide repeats are grey-shaded.
N-terminus, three towards the C-terminus) and also an Xaa-Xaa-
His motif at the N-terminus. All these sequence features indicate
that this protein would bind metal ions strongly. Mutated strains
of H. pylori lacking the hpn gene are four times more sensitive to
ranitidine bismuth citrate, a metal-containing drug widely used
to treat H. pylori infections, than the wild-type [24,25]. Recently,
the H. pylori Ni2+-uptake regulatory protein NikR was found to
up-regulate not only the expression of the urease subunit genes,
but also the expression of the nixA and hpn genes in the presence
of excess Ni2+ [20]. This suggested that H. pylori may respond
in a co-ordinated manner to the presence of excess extracellular
Ni2+, to allow the optimal import of Ni2+ ions (up-regulation of the
nixA gene), optimal incorporation of Ni2+ into other proteins, as
well as optimal storage of the free Ni2+ ions (up-regulation of the
hpn gene) to minimize any toxic effects due to their accumulation
[20].
In the present paper, we describe the cloning, expression, puri-
fication and characterization of the Hpn protein from H. pylori.
Most notably, our results indicate that the Hpn protein exists in
an equilibration of multimeric states in solution, and binds Ni2+
ions reversibly.
MATERIALS AND METHODS
Bacterial strains and growth conditions
H. pylori 26695 was a gift from Department of Medicine, the
University of Hong Kong, and was cultured on Brucella agar
(Difco) plates supplemented with 10% defibrinated sheep blood
at 37 ◦C under microaerophilic conditions (5% CO2, 4% O2 and
91% N2), maintained by CampyPak Plus (BBL). Plasmid DNA
was maintained in Escherichia coli DH10B. E. coli BL21(DE3)
(Stratagene) was used to express the hpn gene. Amp (ampicillin)
(100 μg/ml) and IPTG (isopropyl β-D-thiogalactoside) (0.5 mM)
were added to LB (Luria–Bertani) broth (USB) when indicated.
Chromosomal hpn-deletion mutants were constructed as de-
scribed previously by electroporating plasmid pHPN2KO (kindly
supplied by A. G. Plaut, GRASP Digestive Disease Research
Center, Tufts-NewEnglandMedical Center, Boston,MA,U.S.A.)
into H. pylori 26695 cells in 10% (v/v) glycerol (Bio-Rad gene
pulser at 12.5 kV/cm, 25 μF, 600 ) [26]. Kanamycin-resistant
colonies were isolated, and cell lysates of cultures grown from
individual clones were analysed for Hpn production by Western
blot analysis, to confirm gene deletion.
DNA techniques
Standard DNA manipulations were performed as described by
Maniatis et al. [27], or as recommended by the manufacturers.
Plasmid DNA was isolated using the QIAprep Spin mini kit
(Qiagen). DNA fragments were purified from 1.0% agarose gels
[in 1×TAE (Tris/acetate/EDTA)] with the QIAquick gel extrac-
tion kit (Qiagen). PCR was performed on a PerkinElmer 2400
thermal cycler using the Expand High Fidelity PCR System
(Roche). Oligonucleotide primers were synthesized by Proligo
(Singapore). The hpn gene (HP1427) was amplified from unpuri-
fied H. pylori 26695 genomic DNA (from a picked colony) by
PCR using primer 1 (5′-TATTCCATGGCTCATATGGCACACC-
ATGAAGAACAGCAC-3′) and primer 2 (5′-TATACTCGAGTT-
ACTCGTGATGCCCGTGGCAGCAACC-3′), which introduce
NdeI and XhoI restriction sites (underlined) at the 5′- and 3′-
ends of the PCR product respectively. After restriction digestion,
the PCR products were ligated into the expression vector pET-
32a (Novagen), pre-cut with the same enzymes and gel-purified,
to generate the plasmid pET-hpn. The plasmid was sequenced
using ABI Prism BigDye (Applied Biosystems) and subsequently
transformed into E. coli BL21(DE3) as described previously [27]
for protein expression.
Expression and purification of Hpn
A saturated overnight culture of pET-hpn/E. coli BL21(DE3) was
expanded (1:100) in LB medium supplemented with 100 μg/ml
Amp, 0.5 mM NiSO4 and 0.5% glucose, and was grown at 37 ◦C
until a D600 of 0.7 was reached. Protein expression was induced
by the addition of IPTG to 0.5 mM, and the cultures were then
incubated for a further 4 h at 37 ◦C, before chilling to 4 ◦C. Cells
were harvested by centrifugation at 5000 g for 20 min at 4 ◦C
and were resuspended in 10 ml of ice-cold Buffer A (20 mM so-
diumphosphate buffer, pH 7.4, 500 mMNaCl, 100 mM imidazole
and 1 mM PMSF) per litre of cell culture. Bacteria were ruptured
by sonication in the presence of 1% (v/v) Triton X-100. The
lysate was centrifuged at 30000 g for 30 min, and the supernatant
was filtered through a 0.45-μm-pore-size cellulose acetate syringe
filter (Iwaki Glass) before loading on to a NiSO4-impregnated
HiTrap Chelating HP column (5 ml; Amersham Biosciences) that
had been pre-equilibrated with 10 column vol. of Buffer A. After
washing with 10 column vol. of Buffer A, Hpn protein was
eluted with Buffer B (20 mM sodium phosphate buffer, pH 7.4,
500 mM NaCl and 500 mM imidazole). The purest fractions, as
determined by SDS/PAGE (15% gel), were pooled, concentrated
(Centricon YM-3; Millipore) and then purified further by gel-
filtration chromatography on Superdex 75 resin (10/300 column;
Amersham Biosciences) in buffer appropriate for subsequent use.
Protein analysis
Protein concentrations were determined by BCA (bicinchoninic
acid) assay (Bio-Rad) using BSA as the standard. SDS/PAGEwas
performed according to the method of Maniatis et al. [27], and
proteins were visualized with Coomassie Blue R-250.
Immunoblot analysis was used to determine the amount of Hpn
present in the various purified Hpn fractions, using a standard
curve constructed from Hpn solutions of known concentrations.
Fractions were resolved on SDS/15% polyacrylamide gels then
transferred on to PVDF membranes (Hybond-P; Amersham
Bioscience). After unoccupied sites were blocked with 5% (w/v)
non-fat dried milk in TTBS [Tris-buffered saline with Tween
20: 10 mM Tris/HCl, 150 mM NaCl, 0.01% (v/v) Tween 20],
membranes were incubated with His ·Tag® monoclonal anti-
body (1:1000 dilution) (Novagen) as recommended by the manu-
facturers. The membranes were then washed three times with
TTBS, incubated with anti-mouse IgG conjugated to horse-
radish peroxidase, and developed using the ECL® (enhanced
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chemiluminescence) Western blotting kit (Amersham Bio-
sciences). Image acquisition and analysis were performed on an
ImageScanner (Amersham Biosciences) using ImageMaster 2D
Elite software (Amersham Biosciences).
After resolution on an SDS/15% polyacrylamide gel and
Coomassie Blue staining, the band corresponding to Hpn was
excised and digested in-gel with chymotrypsin (Sigma), with
overnight incubation at 37 ◦C. Peptide fragments were then ana-
lysed by MALDI (matrix-assisted laser-desorption ionization)-
MS.
To confirm the N-terminal sequence of the recombinant Hpn,
the purified protein was subjected to N-terminal analysis by
Edman degradation. Aliquots of Hpn (∼5 μg) was subjected to
SDS/PAGE, transferred on to a PVDF membrane, and stained
with 0.1% Coomassie Blue R-250, before excision and ana-
lysis with an automated HPG1000A liquid-phase protein se-
quencer (Hewlett-Packard).
The free thiolate content of Hpn was determined by the method
of Ellman [28]. Briefly, Hpn protein was added to a 1 mM DTNB
[5,5′-dithiobis-(2-nitrobenzoic acid)] solution in 20 mM Hepes,
pH 7.4, and 100 mMNaCl, to final concentration of 10 μM. After
incubation for 2 h at room temperature (25 ◦C), the amount
of generated p-nitrothiolate was determined using the molar
absorption coefficient (ε412) of 13600 M−1 · cm−1 [28].
Determination of the multimerization state of Hpn
To examine the effects of imidazole and DTT (dithiothreitol), as
well as Ni2+ binding, on the multimerization state of Hpn, pro-
teins (50 μM) were injected into a Superose 12 (10/300 column)
(Amersham Biosciences) gel-filtration column, using running
buffers containing 20 mM Hepes, pH 7.4, and 500 mM NaCl,
supplemented with 100 or 500 mM imidazole, 5 mM DTT or
250 μM Ni2+ (as NiSO4) when needed. The proteins were equil-
ibrated in the respective running buffer for at least 1 h before
injection into the column. The column was calibrated with vita-
min B12 (1.355 kDa), lysozyme (14.3 kDa), β-lactoglobulin
(35 kDa), BSA (66 kDa), human transferrin (80 kDa) and IgG
(150 kDa). Blue Dextrin was used to determine the void vol-
ume. Molecular masses were determined by plotting log mol-
ecular masses of the standards against the partition coefficient
(Kav), where Kav = (V e −V0)/(V t −V0), where V e represents elu-
tion volume, V0 is the void volume, and V t is the total column vol-
ume. The aggregation state of recombinant Hpn protein was also
analysed by non-denaturing PAGE, according to the method of
Coligan et al. [29], calibrated with high-molecular-mass native
markers (Amersham Biosciences) and stained using Coomassie
Blue R-250.
UV/vis (visible) spectroscopy
Unless otherwise indicated, UV/vis absorption measurements
were performed on samples of 50 μM proteins in 20 mM Hepes,
pH 7.4, and 100 mM NaCl, using a Varian Cary 3E UV/vis
spectrophotometer. Spectra were recorded over the wavelength
range 230–650 nm in cuvettes with a pathlength of 1.0 cm.
CD spectroscopy
CD measurements were measured on a Jasco J-720 spectro-
polarimeter calibrated with a 0.06% (+)-10-camphorsulphonic
acid solution (Sigma–Aldrich), using a 0.1-cm-pathlength quartz
cell. CD data were obtained for 5 μM Hpn in Tris/HCl buffer,
pH 7.4, in both the absence and the presence of 1–5 molar
equivalents of Ni2+ (as NiSO4). Instrument optics and sample
chamber were continually flushed with 3 litres/min of dry N2 gas.
Instrument settings used were: scan range, 190–250 nm; scan
rate, 20 nm/min; wavelength step, 0.25 nm; sensitivity, 5 milli-
degrees; response time, 8 s. The final spectrum, representing an
average of six scans, was corrected for the corresponding buffer
and smoothed using adjacent averaging or an FFT (fast Fourier
transform) filter. Quantitative estimations of the secondary-struc-
ture contents were made using the CDPro software package [30].
Influence of Ni2+ and Hpn on the growth of E. coli
(i) E. coli BL21(DE3) cultures, both with and without the plasmid
pET-hpn (inoculated from individual colonies), were grown in LB
medium (containing 100 μg/ml Amp when required) at 37 ◦C.
Stationary-phase overnight cultures (1 ml) were added to 50 ml
of fresh medium supplemented with 500 μM NiSO4, and were
incubated for 24 h at 37 ◦C, with IPTG added where applicable
(to a final concentration of 500 μM) when the D600 was approx.
0.6. Cell densities (determined by D600) were measured after 0, 2,
4, 8, 16 and 24 h.
(ii) E. coli BL21(DE3) overnight cultures (as above, 10 μl)
were used to inoculate 1 ml of fresh medium containing 0, 50,
100, 200, 500, 600, 700 or 800 μMNiSO4 (as indicated). Cultures
were grown for 18 h at 37 ◦C, with IPTG added where applicable
(to 500 μM), before the final cell density (determined by D600)
was measured.
Ni2+ accumulation in E. coli
E. coli BL21(DE3) overnight cultures (as above, 10 μl) were
added to 1 ml of fresh medium supplemented with 500 μM
NiSO4. Cultures were grown for 18 h at 37 ◦C, with IPTG (1 M)
added when required (to a final concentration of 0.5 mM) when
the D600 reached approx. 0.6. Cells were pelleted at 4000 g for
10 min and washed three times with PBS, and the cellular Ni2+
content was determined by ICP-MS (inductively coupled plasma
MS) (Agilent 7500) with 207Tl as an internal reference.
Ni2+ accumulation in H. pylori
Wild-type or hpn mutant H. pylori 26695 cells from fresh plates
were resuspended in 10 ml of Brucella broth supplemented with
5% foetal bovine serum and 0.2 mM NiSO4, and were grown
for 48 h at 37 ◦C. Cells were pelleted at 4000 g for 10 min and
washed three times with PBS. The cellular Ni2+ content was
then determined by ICP-MS similarly. All of the accumulation
experiments were carried out with three replicates and an average
value was used.
Ni2+ binding to Hpn
Binding of Ni2+ to Hpn was determined by equilibrium dialysis.
The dialysis tubes (molecular-mass cut-off of 1 kDa), filled with
200 μl of protein suspension (5 μM), were placed into 1000 ml
of 20 mMHepes and 100 mMNaCl, pH 7.4, supplemented with a
series of concentrations of Ni2+ from 0 to 100 μM, for overnight
incubation at 4 ◦C. The Ni2+ concentrations inside and outside
the dialysis tubes were determined by ICP-MS. Each assay was
repeated in triplicate. The results were subjected to Hill analysis
for the determination of the stoichiometry and the binding affinity.
Alternatively, 15 molar equivalents of Ni2+ (as NiSO4) were
added to 5 μM protein in 20 mM Hepes at pH 7.4. After more
than 1 h, the mixture was loaded on to a PD-10 desalting column
(AmershamBiosciences) to remove excessNi2+ ions. The fraction
containing the Hpn–Ni2+ complex was collected, and the Ni2+
concentration was determined by ICP-MS.
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Table 1 Purification of expressed Hpn
The protein content was determined using a BCA protein concentration assay (Bio-Rad). Hpn
was quantified from an immunoblot using the His · Tag® monoclonal antibody, normalized
against a standard curve of different Hpn concentrations. The percentage Hpn in the fraction was
calculated as follows: (mg of Hpn/mg of total protein)× 100.
Fraction Total protein (mg) Hpn (mg) Hpn in fraction (%) Fold purification
Crude extract 5300 2.6 0.05 1
Crude supernatant 3279 2.5 0.08 1.6
Ni2+ affinity 2.7 2.3 85 1700
Gel filtration 1.5 1.4 >97* 1940
* As determined from a Coomassie Blue-stained gel.
RESULTS
Expression and purification of Hpn
The hpn gene (HP1427) was amplified by PCR from genomic
H. pylori DNA and inserted into pET32a, via the NdeI/XhoI re-
striction sites, for high-level expression in E. coli. No fusion tag
was included as we predicted that the separate stretches of six
and seven consecutive histidine residues within the Hpn protein
would result in strong binding to Ni2+-charged iminodiacetate-
derivatized agarose (HiTrap chelating Sepharose). DNA sequenc-
ing revealed that the cloned hpn gene contained several (silent)
mutations compared with the published sequence (GenBank®
accession number U26361), but the translated product remained
unchanged. It was found that adding IPTG to 0.5 mM at a D600
of 0.6–0.8, followed by incubation at 37 ◦C for 4 h, was optimal
for the expression of soluble protein from pET-Hpn in E. coli
BL21(DE3). Under these conditions, generally 2–3 mg of soluble
Hpn was expressed per litre of cell culture. Hpn bound strongly
to the Ni-charged chelating Sepharose resin in the presence of
100 mM imidazole, and could be eluted by 500 mM imidazole.
After a second gel-filtration purification step, Hpnwas determined
to be>95–97% pure byCoomassieBlue staining (Table 1). Upon
storage for several days at 4 ◦C in gel-filtration buffer (which
lacked imidazole), the Hpn protein progressively aggregated and
precipitated. This could be prevented by the addition of imidazole
(500 mM), which increased protein stabilities in solutions to over
1 month (as determined by SDS/PAGE).
To confirm the identity of the purified recombinant Hpn protein,
we performedWestern blotting, N-terminal protein sequence ana-
lysis and MALDI–TOF (time-of-flight) mass spectrometric
analysis. Based on the presence of six and seven consecutive histi-
dine residues in the Hpn protein sequence, we predicted that it
would bind with the His ·Tag® monoclonal antibody with good
affinity. Western blotting experiments confirmed this prediction,
with a single intense band appearing on the PVDF membrane
(Figure 2A), corresponding to the migratory position of the Hpn
protein on a 15% polyacrylamide gel (as a weak band; results not
shown).
To performN-terminal sequencing, Hpnwas purified byHiTrap
Chelating HP to approx. 95% homogeneity, resolved further by
SDS/PAGE, and then electroblotted on to a PVDF membrane to
isolate homogeneous protein for N-terminal sequencing. The first
seven amino acids were determined to be Ala1-His-His-Glu-Glu-
Gln-His7. This revealed that the N-terminal methionine residue
had been removed co- or post-translationally in E. coli. MALDI–
MS spectrometry of the Hpn digested in-gel with chymotrypsin
revealed a major peak at m/z 2773.183 (Figure 2D). This value
agrees very well with the mass of m/z 2773.178 for the peptide
AHHEEQHGGHHHHHHHTHHHHY of Hpn as predicted by
analysis with MS-digest software (http://prospector.ucsf.edu/).
Figure 2 Analysis of expressed Hpn protein
(A)Western blottingwithHis · Tag® antibody. The arrow indicates the position of the recombinant
Hpn protein. (B) Purified Hpn subjected to SDS/20% PAGE. The left-hand lane contains
the protein markers (sizes are given in kDa), and the right-hand lane contains purified Hpn
protein, which migrates to approx. 7 kDa. (C) Purified Hpn subjected to SDS/15% PAGE. The
left-hand lane contains the protein markers (sizes are given in kDa), and the right-hand lane
contains purified Hpn protein, which migrates to approx. 16 kDa. (D) MALDI-MS spectrum
of Hpn showing the major peak at m/z 2773.183 corresponding to the N-terminal fragment of
recombinant Hpn.
Analysis using Ellman’s reagent revealed that there were 3.7
thiolate groups per monomer, indicating that four cysteines in
Hpn were in reduced form.
Molecular size
As was found previously [23], on standard SDS/10–15% poly-
acrylamide gels, Hpn migrated with an apparent molecular mass
of approx. 16 kDa (Figure 2C), which is considerably larger than
its predicted molecular mass of approx. 7 kDa. This is consistent
with the properties of other histidine-rich proteins, which also
exhibit retarded migration on SDS/polyacrylamide gels [32].
However, when SDS/20% polyacrylamide gels were used, Hpn
migrated with an apparent molecular mass of approx. 7 kDa (Fig-
ure 2B), which corresponds closely to its predicted monomeric
mass (7077 Da).
The native molecular mass of the protein in the presence of im-
idazole, DTT and Ni2+ was estimated by gel-filtration chromato-
graphy. As shown in the elution profile (Figure 3A), in the
presence of 100 mM imidazole, a large fraction of the purified
recombinant Hpn formed a high-molecular-mass aggregate of
>500 kDa (eluted at approx. 8.1 ml). There were six other major
species observable, corresponding to molecular masses of 55,
34, 26, 20, 14 and 7 kDa, suggesting that Hpn was present in a
range of multimeric forms. However, when DTT was added to
the Hpn solution to a final concentration of 5 mM, before loading
on to the Superose 12 column, the relative amount of the high-
molecular-mass aggregate (eluted at approx. 8.1 ml) decreased
significantly (Figure 3B), and the majority of the protein eluted
c© 2006 Biochemical Society
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Figure 3 Analysis of Hpn multimeric state using gel-filtration chromato-
graphy
Elution profile (monitoring at 280 nm) of Hpn after gel filtration on Superose 12 (10/300) column,
using running buffers containing 20 mM Hepes, pH 7.4, and 500 mM NaCl, supplemented with
(A) 100 mM imidazole, (B) 100 mM imidazole plus 5 mM DTT, or (C) 500 mM imidazole plus
5 mMDTT. Proteins were equilibrated in the respective running buffer for at least 1 h immediately
before analysis.
with an apparent molecular mass of 136 kDa (eluted at approx.
10.4 ml), with two very minor peaks at 55 and 26 kDa. When the
eluted fraction corresponding to 136 kDa was re-injected into
the gel-filtration column under the same conditions, a similar
elution profile was observed (results not shown), suggesting
that an equilibrium exists between multimeric forms. When the
amount of imidazole was increased to 500 mM in the presence
of 5 mM DTT, this fraction (approx. 136 kDa) become the domi-
nant species with little high-molecular-mass aggregate (approx.
8.1 ml of eluate) (Figure 3C). When analysed on a SDS/15%
polyacrylamide gel, all of the separately collected fractions
migrated with an similar molecular mass of approx. 16 kDa (as in
Figure 2C), showing that they are the same protein with different
multimerization states.
Ni2+–Hpn interaction
As shown in Figure 3, Hpn was present mainly as a 136 kDa mul-
timer in buffers containing 500 mM imidazole and 5 mM DTT;
otherwise, it will aggregate to over 500 kDa (Supplementary Fig-
ure S1 at http://www.BiochemJ.org/bj/393/bj3930285add.htm).
It is impossible to investigate the Ni2+ binding in the presence
of high concentrations of imidazole and DTT because of their
competitive metal-binding capabilities. Therefore we studied the
‘effective’ Ni2+-binding mode under physiologically relevant
conditions (without imidazole). The choice of these experimental
conditions was supported further by the findings that Hpn (2% of
the total proteins of H. pylori) was absent in the two-dimensional
gels of H. pylori cellular protein fractions (R. Ge, Q.-Y. He,
Figure 4 Binding of Ni2+ to recombinant Hpn as determined by UV/vis
absorption spectra
(A) UV/vis absorption spectra of Hpn (50 μM) in 20 mM Hepes, pH 7.4, and 100 mM NaCl
(lower trace) and after addition of 5 molar equivalents of Ni2+ (as NiSO4) (upper trace). Inset,
pH titration of Ni2+-saturated Hpn, monitoring the putative Ni2+–protein LMCT at 335 nm.
(B) Kinetics of Ni2+ release from Hpn in the presence of 120 molar equivalents of EDTA at
pH 6.8 and 298 K, as indicated by the absorption at 335 nm.
J.-D. Huang and H. Sun, unpublished work), indicating that Hpn
was unlikely to be present as a monomer inside theH. pylori cells.
The binding of Ni2+ with apo-Hpn was studied by ICP-MS.
It was found that freshly prepared Hpn contained fewer than
one Ni2+ ion per ten Hpn molecules (results not shown). To a
solution of Hpn (50 μM, in 20 mM Hepes buffer at pH 7.4),
15 molar equivalents of Ni2+ (as NiSO4) were added, then the
excess Ni2+ was removed by desalting on a PD-10 column. The
Hpn-bound Ni2+ was quantified by comparing the amount of Ni2+
present in the protein fraction with a standard curve (results not
shown). This revealed that 5.1+− 0.2 (n= 3, mean+− S.D.) Ni2+
ions were present per Hpn monomer. In order to examine whether
free cysteine residues in Hpn were involved in the Ni2+ binding,
the Ni2+-bound Hpn was subjected to the method of Ellman [28],
and the number of free thiolate groups was determined to be 0.4,
indicating that almost all the four cysteine residues took part in
the Ni2+ binding.
UV/vis spectroscopy was used to characterize further the Ni2+–
Hpn interaction. Complexation of Ni2+ to proteins normally
leads to the production of new absorptions in the visible region
due to LMCT (ligand-to-metal charge transfer) transitions [33].
Consequently, these new absorption peaks can be readily used to
monitor protein–metal binding. The UV/vis absorption spectrum
of a 50 μM Hpn solution was recorded (Figure 4A). After
the sequential addition of differentmolar equivalents ofNi2+ to the
purified protein solution, two shoulder peaks gradually appeared,
centred at approx. 286 and 335 nm, indicative of Ni2+ binding
(Figure 4A). The band at 335 nm was attributed to a ligand
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Figure 5 Binding of Ni2+ to recombinant Hpn as determined by equilibrium
dialysis
Hpn (5 μM, 200 μl) was dialysed overnight at 4◦C against 1000 ml of 20 mM Hepes, pH 7.4,
and 100 mM NaCl containing 0, 2, 5, 10, 20, 30, 40, 60 or 100 μM NiSO4. Hpn-bound Ni2+ was
determined by ICP-MS (subtracting Ni2+ concentrations inside and outside the dialysis tubing).
Shown is a Hill plot of the molar ratio (r) of bound Ni2+ to Hpn protein against concentration
of NiSO4 in the dialysis buffer. Each point represents the average value of three independent
experiments.
[e.g. N(His)]→Ni2+ LMCT transition [34]. A plot of ε286
against the molar ratio (r) of Ni2+ (as NiSO4) to the apo-
protein is also shown in Supplementary Figure S2 (http://
www.BiochemJ.org/bj/393/bj3930285add.htm). It can be seen
that with the increase of r, the absorption at 286 nm (and 335 nm)
increases in intensity and reaches a plateau at r ≈ 4.8+− 0.2, which
suggests that five Ni2+ ions bind strongly per Hpn monomer.
We investigated how the intensity of the absorption at 335 nm
altered as the pH of a Ni2+-saturated Hpn solution was system-
atically varied. As can be seen in the inset of Figure 4(A), there
were no significant changes in the absorption at 335 nm at pH
values greater than approx. 6.8. This indicated that the amount
of Ni2+ bound to the protein remained relatively stable above this
pH value. However, upon lowering the pH of the solution from
approx. pH 6.8 to 5.8 (by the careful addition of 1 M HCl), the
intensity of the absorption at 335 nm decreased markedly. At pH
values lower than approx. 5.0, the absorption at 335 nm remained
essentially unchanged. The pH for half dissociation of Ni2+ from
the protein complex (pH1
2
) was determined to be 6.3+− 0.1.
A competition binding assay between Hpn and EDTA for free
Ni2+ was performed analogously. Upon the addition of a large
excess of EDTA (120 molar equivalents) to a Ni2+-saturated Hpn
solution at pH 6.8, the absorption at 335 nm (characteristic of an
LMCT) decreased exponentially with a half-life of 41+− 1 min(Figure 4B). However, this peak was restored to original levels
upon the addition of excess Ni2+ ions, demonstrating that Ni2+
binding is reversible (results not shown).
To determine the Ni2+-binding affinity and capacity of the
protein, the pure proteinwas dialysed against 20 mMHepes buffer
(pH 7.4) with different amount of Ni2+. As shown in Figure 5, at
the concentration used (5 μM), the binding ofNi2+ to Hpn reached
saturation at 40 μM, and the protein was able to bind to 4.8+− 0.1
Ni2+ ions per monomer in a slightly co-operative fashion (Hill
coefficient of approx. 1.7). The dissociation constant (Kd) was
calculated to be 7.1 μM.
The CD spectrum of Hpn in 20 mM Tris/HCl at pH 7.4 (Fig-
ure 6) is characterized by a negative peak with a minimum at
approx. 217 nm and a positive peak with a maximum at 197 nm,
attributed to the presence of amixture ofα-helix,β-sheet, turn and
unordered form. Upon the addition of different amounts of molar
equivalents of Ni2+ ions (as NiSO4) to the apo-protein solution,
the negative peak at 217 nm increased gradually, indicative of a
conformational change within the protein induced by the metals.
Quantitative analysis using CDPro [30] indicated that α-helix
Figure 6 Binding of Ni2+ to recombinant Hpn as determined by CD
CD data were obtained for 5 μM Hpn in Tris/HCl buffer, pH 7.4, in both the absence and the
presence of 1–5 molar equivalents of Ni2+ (as NiSO4). The arrow indicates the increases in
ellipticity values (approx. 217 nm) as the protein was titrated with 0–5 molar equivalents of
Ni2+.
Figure 7 Effects of Ni2+ on growth of E. coli and Ni2+ accumulation in E. coli
and in H. pylori
(A) Growth curves of freshly inoculated cultures of E. coli BL21(DE3) both with and without the
hpn gene (pET-hpn) in LB medium containing Ni2+ (as NiSO4, 500 μM). (B) The influence of
Hpn expression on the growth of E. coli BL21(DE3) cells cultured in LB medium supplemented
with NiSO4 at 0, 50, 100, 200, 500 or 800 μM.,+pET-hpn, with IPTG induction (0.5 mM);H17009,
+pET-hpn, no IPTG induction;, −pET-hpn, with IPTG induction (0.5 mM);, −pET-hpn,
no IPTG induction. (C) E. coli BL21(DE3) cells were cultured in LB medium supplemented
with 500 μM NiSO4, with or without the plasmid pET-Hpn, and with or without IPTG induction
of Hpn expression. (D) The wild-type and Hpn-deleted H. pylori 26695 cells were cultured in
fresh Brucella broth supplemented with 5% foetal bovine serum and 200 μM NiSO4. The Ni2+
content associated with the cell pellet was determined using ICP-MS.
content was reduced from approx. 20% to 10%, whereas the β-
structure increased from 22% to 37% after addition of 5 molar
equivalents of Ni2+.
Effect of Ni2+ on the growth of E. coli
E. coli BL21(DE3) cells with and without the plasmid pET-hpn
were grown in LB medium supplemented with different amounts
of NiSO4. The growth at 37 ◦C in the presence of 500 μM Ni2+,
as a representative, was followed by the measurement of D600
values (Figure 7A). The D600 values for the E. coli BL21(DE3)
cells with hpn were about twice those of cells without hpn
after 8 h. In addition, the D600 values for the E. coli BL21(DE3)
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cells with hpn were slightly higher upon addition of IPTG than
those without (Figure 7B). In contrast with the very similar
D600 values for the E. coli BL21(DE3) cells with hpn grown
at [Ni2+] 500 μM, the D600 values for the E. coli BL21(DE3)
cells without hpn fell significantly at [Ni2+] 200 μM. More
importantly, the difference in D600 values (overnight culture) for
E. coli BL21(DE3) cells harbouring hpn became more evident
with Ni2+ concentrations increased to 500 μM or over with
and without IPTG, i.e. the D600 values were higher for those cells
with IPTG than for those without.
Cellular Ni2+ accumulation
To comply with the conditions used in the expression of Hpn,
the cells treated with 0.5 mM Ni2+ were pelleted and washed
three times with PBS, and the cellular Ni2+ content was deter-
mined by ICP-MS. In E. coli BL21(DE3) harbouring pET-hpn
where Hpn expression had been induced with IPTG, the Ni2+
ion content was found to be approx. 4-fold higher than in un-
induced cells, or in cells that did not contain pET-hpn (Fig-
ure 7C). The cellular accumulation of Ni2+ was then investigated
in cultures of H. pylori 26695 which contained a wild-type copy
of the gene, and in constructed strainswhere the hpn gene had been
deleted. The deletion of the hpn gene was confirmed by PCR
(Supplementary Figure S3 at http://www.BiochemJ.org/bj/393/
bj3930285add.htm), and by the disappearance of the Hpn protein
from cell lysates, using Western blot analysis, probing with
the His ·Tag® monoclonal antibody. After 48 h of culture in
medium containing 0.2 mM NiSO4, ICP-MS analysis indicated
that intracellular levels of Ni2+ were 1.5-fold higher in the wild-
type strain than in the hpn strain (Figure 7D). In addition, the
accumulation of Ni2+ in H. pylori 26695 is at least 2-fold greater
than that in E. coli, on a gram-for-gram basis (wet cell mass).
DISCUSSION
The transition metal Ni2+ is essential for anaerobic metabolism
in micro-organisms, including the medically important Gram-
negative bacterium H. pylori. However, too much ‘free’ or un-
bound Ni2+ can be toxic and therefore intracellular concentrations
must be regulated tightly [10,13]. Initial studies have indicated
that the small cytoplasmic Hpn protein may play a pivotal role
in Ni2+ homoeostasis, binding or transport [23], and Hpn was
named to emphasize its origins in H. pylori and its affinity for
Ni2+ [23]. Although the specific amino acids essential for metal
binding remain to be established, several conserved histidine,
glutamate and aspartate residues stand out as potential metal
ligands. All four cysteine residues of Hpn were found to be in-
volved in Ni2+ binding. It is possible that the two neighbouring
double cysteines seem to be possible to take part in the co-
ordination with the same Ni2+ ion. The motif Asp-Xaa-His-His-
Xaa-Xaa-Glu (or DXHHXXE) is a potential metal-binding site,
and is conserved in approx. 300 proteins listed in the SwissProt
database ([35]; http://www.expasy.org/sprot/). A significant pro-
portion of these proteins are histidine-rich and have been im-
plicated in metal binding, such as UreE [36], IGPD (imidazole
glycerol-phosphate dehydratase) [37], HspA and HypB [38,46].
Another conserved pentapeptide motif: His-Glu-Xaa-Xaa-His
(or HEXXH) appears regularly in protein sequences, especially
in metallopeptidases. Roughly half of all metallopeptidases
characterized to date contain thismotif, which has been implicated
in metal binding in X-ray crystal structures [39]. Low-stringency
homologous sequence searching using various BLAST programs
[40] failed to find anymeaningful proteinmatches toHpn, the only
‘hits’ containing ubiquitous short histidine-richmotifs (results not
shown). Consequently, the structural fold and organization of Hpn
cannot presently be inferred by homology.
The hpn gene was cloned into a pET32 vector, and was success-
fully expressed (untagged) in a predominantly soluble form in
E. coli. Approx. 77% of the amino acid residues in Hpn are
predicted to be >16% solvent-exposed using PredictProtein
([41]; http://cubic.bioc.columbia.edu/predictprotein/), indicating
that the protein should be highly hydrophilic. Denaturing condi-
tions were not required for Hpn binding to Ni2+-impregnated
Sepharose resin, suggesting that enough contiguous histidine resi-
dues are solvent-exposed under the conditions used to be readily
available either for chelation with the immobilized metal ions,
or possibly for protein–protein interactions. This is congruent
with the predicted hydrophilicity of the histidine-rich regions by
PredictProtein (results not shown).
After purifying milligram quantities of recombinant Hpn, we
were able to investigate in detail its multimeric form, conform-
ation and Ni-binding properties in vitro. On native gels, Hpn
migrated as a single band with an apparent molecular mass of
>500 kDa (Supplementary Figure S1 at http://www.BiochemJ.
org/bj/393/bj3930285add.htm). However, it eluted as a mixture
of species after gel-filtration chromatography on a Superose 12
column in a buffer containing 20 mM Hepes, pH 7.4, 500 mM
NaCl and 100 mM imidazole buffer (Figure 3A). Upon addition of
5 mMDTT to the running buffer, the relative amounts of the high-
molecular-mass aggregate dramatically decreased, indicative of
the presence of an intermolecular oxidation. The protein frac-
tions with apparent molecular masses of approx. 55 and approx.
136 kDa correspond to a ‘dimer’ and ‘pentamer’ of tetramers
respectively. It is possible that the 20 (+−2)-merHpnmultimermay
be the physiologically relevant form of the protein in vivo. In the
presence of higher amounts of imidazole, the relative amount of
the high-molecular-mass aggregate decreased further, indicating
that imidazole plays a role in the prevention of protein precipi-
tation and restoring the preferred multimerization state.
A number of other histidine-rich proteins have been reported
to exist as multimers (Supplementary Table S1 at http://www.
BiochemJ.org/bj/393/bj3930285add.htm) [32,37,42–46]. Based
on these data, it seems that the higher the percentage of histi-
dine in a metal-binding protein, the greater the propensity of the
protein to form higher-order multimers. One explanation for this
is that histidine residues located on different protein monomers
might facilitate protein multimerization in some way, possibly
through their tendency to align or ‘stack’ on top of one another.
It is conceivable that the disappearance of the low-molecular-
mass Hpn band (as determined by SDS/PAGE) after storage for
several days in buffers lacking imidazole may be due to the
formation of a high-molecular-mass aggregate that is large enough
to precipitate. Conversely, when present in concentrations of no
less than 500 mM, imidazole in solution may locate between the
protein monomers, inhibiting intermolecular histidine stacking,
consequently stabilizing the protein. However, we cannot exclude
the possibility that other biophysical processes are behind
multimer formation/disassociation.
We have found that Hpn can bind up to five Ni2+ ions
per monomer under physiologically relevant conditions (i.e. at
pH 7.4). More importantly, this binding is reversible, as revealed
by both pH titration experiments and competition binding experi-
ments with EDTA (Figure 4). This result raises the intriguing
possibility that Hpn releases bound Ni2+ ions when the environ-
mental pH decreases to approx. 6.8, a physiological pH value.
The moderate affinity (Kd of approx. 7.1 μM) of Hpn for Ni2+
is comparable with that of HypB (Kd of approx. 2.3 μM), a
protein that has been suggested to store Ni2+ in its N-terminal
histidine-rich region (16 histidine residues out of 54 residues) in
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Bradyrhizobium japonicum [46]. In this manner, H. pylori may
buffer itself against a potentially damaging fall in the environ-
mental pH. As shown in a previous report [23], there appears to
be no direct interaction between Hpn and urease, since hpn gene
deletion has little affect on the urease activity. It is possible that
Hpn may donate Ni2+ to a chaperone protein (e.g. HspA) with
higher affinity, which would transport the Ni2+ ions to other pro-
teins and ultimately to a Ni2+-containing enzyme [21]. The pres-
ence of other functions of the protein is also possible and needs
to be studied further.
Interestingly, Ni2+ release from the protein appeared to occur
in a single process, although one may have expected five micro-
steps (generating micro pKa values). This may be due to the high
kinetic liability of Ni2+ binding. A similar kinetic profile has been
observed for Zn2+ (and Cd2+) release from MT (metallothionein;
Zn7-MT), i.e. no more than two steps were observed [47]. A facile
Ni2+-to-ligand exchange mechanism would facilitate intraprotein
metal transfer, possibly assisting rapid metal trafficking to and
from other proteins or enzymes.
The appearance of absorption peaks at 286 and 335 nm upon
the addition of Ni2+ to apo-Hpn indicates that the Ni2+ is probably
co-ordinated to nitrogen (and thiolate) centres, the majority
presumably from the imidazole moieties of histidine residues.
Similar absorptions have been observed in other Ni2+-binding
proteins such as NikR, a protein known to bind to Ni2+ via three
histidine nitrogens and one cysteine [33,48]. These UV/vis data
also indicated that Ni2+ co-ordinates to ligands in either a 4-co-
ordinated diamagnetic square-planar or a distorted square-planar
geometry [10,34], consistent with silent EPR signals of the Ni2+-
saturated Hpn (results not shown), which suggests that the
Ni2+ ions may be in low-spin states. Further studies are required to
firmly establish the co-ordination geometry of Ni2+-bound Hpn.
Similar to the situation in other metal-binding proteins, CD
spectroscopy revealed that the binding of Ni2+ ions induced a pro-
tein conformational change in Hpn, with the α-helical content re-
duced from approx. 20% to 10%, and β-sheet content increased
from approx. 22% to 37% (Figure 6). We are currently investi-
gating the biological and biophysical significance of this change
in protein structure.
InE. coliBL21(DE3) cells where the expression of the plasmid-
based hpn gene had been induced, clearly Ni2+ had less influence
on the cell growth than in those cells without hpn, based on the
D600 values (Figures 7A and 7B). The higherD600 values forE. coli
BL21(DE3) cells with the hpn gene in the presence of IPTG than
those in the absence of IPTG indicated that Hpn may have a pro-
tective role against excess Ni2+ (and probably other heavy metals)
in the environment. A similar pattern was also observed in
H. pylori previously [25]. These data are in agreement with Ni2+
accumulation by ICP-MS. Ni2+ accumulation from the extra-
cellular milieu was approx. 4-fold higher than in uninduced cul-
tures, or in cells that did not contain the plasmid (Figure 7C). An
analogous Ni2+-accumulation pattern was observed in H. pylori
cultures under similar conditions. As the transmembrane metal
transport machineries in E. coli and H. pylori are quite distinct,
this suggests that Hpn may promote the gradual intracellular
accumulation of Ni2+ through a ‘passive’ (equilibrium-driven)
sequestration mechanism. The slight difference in Ni2+ accu-
mulation between H. pylori and H. pylori with the hpn gene
deleted also suggests that some other proteins, such as Hpn-like
protein, play a similar role in cells.
In view of its short length (60 amino acids) and extremely high
content of potential metal-binding residues, Hpn shares some
similarities with MT, a zinc-storage protein rich in cysteine resi-
dues [47]. MT has been known to play a fundamental role in
the metabolism of zinc and copper under various physiological
conditions and its binding capability to metals is comparable with
that ofHpn towardsNi2+.Moreover,MTalso appears to play a role
in sequestering toxic metals such as Cd2+ and Hg2+. It will be of
great interest to see whether future work reveals any structural or
functional similarities between these two importantmetal-binding
proteins. With its large multimeric quaternary structure, possibly
based around an arrangement of tetramers, Hpn may be regarded
as a ‘ferritin-like’ Ni2+ protein, which regulates levels of Ni2+
within the bacterium.
In conclusion, the 60-amino-acid exceptionally histidine-rich
Hpn protein from H. pylori binds tightly and reversibly to Ni2+
ions in a pH-dependent manner. Hpn binds approx. five Ni2+ ions
per monomer with a Kd of 7.1 μM, and adopts a variety of multi-
meric structures in solution, with the 20 (+−2)-mer form pre-
dominating under mildly reducing conditions. The growth and
accumulation experiments performed under Ni2+ pressure clearly
imply a role forHpn to protect the cells fromhigher concentrations
of external metal ions. Given its high intracellular concentration
in H. pylori (approx. 2% of total protein), our data are consistent
with Hpn functioning as an intracellular ‘reservoir’ of Ni2+ ions,
playing a key role in bacterial Ni2+ homoeostasis.
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